logo
  

Western Union Q2 Results Top Estimates

Western Union Co. (WU) reported net income for the second quarter of $189.3 million or $0.36 per share, compared to $193.8 million or $0.36 per share for the year-ago quarter.

Excluding the impact of the Paymap settlement agreement with the Consumer Financial Protection Bureau, adjusted earnings for the latest quarter were $0.41 per share.

Total revenue for the second quarter fell 2% to $1.38 billion from $1.41 billion a year ago.

Analysts polled by Thomson Reuters expected the company to earn $0.39 per share on revenue of $1.36 billion for the second quarter. Analysts' estimates typically exclude special items.

For the full year 2015, the company now forecasts Low to mid-single digit revenue decrease, earnings of $1.55 to $1.62 per share and adjusted earnings of $1.60 to $1.67 per share. Previously, the company forecast low to mid-single digit revenue decrease and earnings of $1.58 to $1.65 per share. Analysts currently expect the company to earn $1.63 per share on revenue decline of 2.90% for the full year 2015.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT